| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662096 | International Journal of Cardiology | 2018 | 4 Pages |
Abstract
In patients with ACS-ACC, β-blocker treatment was associated with a significantly better clinical outcome, with lower rates of death and MI. Our findings support the evidence for long-term β-blocker administration in high-risk patients and highlight the need for large prospective multicenter studies of β-blocker treatment in ACS-ACC.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Germán Cediel, Xavier Carrillo, Cosme GarcÃa-GarcÃa, Ferran Rueda, Teresa Oliveras, Carlos Labata, Jordi Serra, Marc Ferrer, Oriol de Diego, Antoni Bayés-GenÃs,